Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Exscientia Ltd ADR (EXAI)

Exscientia Ltd ADR (EXAI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.84 +0.15 (+3.20%) 11/19/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.84 unch (unch) -
Quote Overview for Tue, Nov 19th, 2024
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.49
Day High
4.85
Open 4.63
Previous Close 4.69 4.69
Volume 1,510,000 1,510,000
Avg Vol 828,720 828,720
Stochastic %K 20.35% 20.35%
Weighted Alpha -23.84 -23.84
5-Day Change -0.98 (-16.84%) -0.98 (-16.84%)
52-Week Range 3.80 - 7.91 3.80 - 7.91
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 632,927
  • Shares Outstanding, K 130,770
  • Annual Sales, $ 24,980 K
  • Annual Income, $ -181,560 K
  • EBIT $ -213 M
  • EBITDA $ -198 M
  • 60-Month Beta 0.83
  • Price/Sales 23.96
  • Price/Cash Flow N/A
  • Price/Book 1.76
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.51
  • Most Recent Earnings $-0.52 on 11/08/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +69.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.45 +8.76%
on 11/18/24
Period Open: 5.21
6.49 -25.42%
on 11/11/24
-0.37 (-7.10%)
since 10/18/24
3-Month
4.45 +8.76%
on 11/18/24
Period Open: 5.49
6.49 -25.42%
on 11/11/24
-0.65 (-11.84%)
since 08/19/24
52-Week
3.80 +27.37%
on 08/05/24
Period Open: 6.10
7.91 -38.81%
on 02/12/24
-1.26 (-20.66%)
since 11/17/23

Most Recent Stories

More News
NVIDIA Invested in These 2 AI Stocks, Should You?

Discover 2 compelling AI stocks NVIDIA (NASDAQ: NVDA) has invested in. Learn how the AI leader's vision can guide your portfolio in the tech revolution.

SERV : 13.85 (-39.57%)
NVDA : 138.85 (+2.63%)
OUST : 9.83 (-2.58%)
MGA : 37.85 (-4.59%)
SHAK : 108.40 (-0.79%)
RXRX : 10.53 (+23.88%)
EXAI : 4.84 (+3.20%)
RHHBY : 41.0500 (-0.58%)
CMG : 57.08 (-1.81%)
UBER : 79.42 (-1.08%)
SNY : 54.50 (+0.94%)
Inside the AI-Healthcare Boom: Breakthroughs in Diagnostics and Personalized Treatment

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems...

MSFT : 408.43 (-0.51%)
NVDA : 138.85 (+2.63%)
TWST : 47.59 (+1.54%)
AVAI : 0.6100 (-3.17%)
ABSI : 5.82 (+16.40%)
RXRX : 10.53 (+23.88%)
EXAI : 4.84 (+3.20%)
1 AI Biotech Stock That Just Scored a Major Milestone

Down over 85% from all-time highs, Recursion Pharmaceuticals is an AI-powered biotech company that aims to accelerate the drug discovery process.

BAYZF : 22.6200 (-0.62%)
RXRX : 10.53 (+23.88%)
EXAI : 4.84 (+3.20%)
SNY : 54.50 (+0.94%)
AI in Healthcare Set for Explosive Growth with Projections Hitting $613 Billion by 2034

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Health care is undergoing a tech revolution, with health systems increasingly leveraging artificial intelligence (AI)...

BLFY : 10.01 (+0.50%)
AVAI : 0.6100 (-3.17%)
GEHC : 92.21 (-1.36%)
RXRX : 10.53 (+23.88%)
EXAI : 4.84 (+3.20%)
AI Revolution in Healthcare Gains Momentum as FDA Prepares for Tech Boom

/CNW/ -- USA News Group – Health care is undergoing a tech revolution, with health systems increasingly leveraging artificial intelligence (AI) bots for...

BLFY : 10.01 (+0.50%)
AVAI : 0.6100 (-3.17%)
GEHC : 92.21 (-1.36%)
RXRX : 10.53 (+23.88%)
EXAI : 4.84 (+3.20%)
The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why.

Merging with a former rival will bolster its capabilities.

NVDA : 138.85 (+2.63%)
RXRX : 10.53 (+23.88%)
EXAI : 4.84 (+3.20%)
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:EXAI),(NASDAQ:TWST),(NYSE:IQV) EQNX::TICKER_END

AVAI : 0.6100 (-3.17%)
RXRX : 10.53 (+23.88%)
EXAI : 4.84 (+3.20%)
TWST : 47.59 (+1.54%)
IQV : 193.44 (-1.33%)
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

AVAI : 0.6100 (-3.17%)
RXRX : 10.53 (+23.88%)
EXAI : 4.84 (+3.20%)
TWST : 47.59 (+1.54%)
IQV : 193.44 (-1.33%)
Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia?

The leading company pioneering artificial intelligence (AI)-fueled drug discovery could get much bigger.

EXAI : 4.84 (+3.20%)
RXRX : 10.53 (+23.88%)
3 Small-Cap Stocks to Invest in AI Drug Development

As AI continues to reshape the drug development landscape, here are three promising small-cap biotech stocks worth considering now.

RXRX : 10.53 (+23.88%)
SDGR : 24.85 (+1.72%)
EXAI : 4.84 (+3.20%)
NVDA : 138.85 (+2.63%)

Business Summary

Exscientia plc is an AI-driven pharmatech company. It involved in discovering, designing and developing drugs. Exscientia plc is based in OXFORD, England.

See More

Key Turning Points

3rd Resistance Point 5.33
2nd Resistance Point 5.09
1st Resistance Point 4.97
Last Price 4.84
1st Support Level 4.60
2nd Support Level 4.36
3rd Support Level 4.24

See More

52-Week High 7.91
Fibonacci 61.8% 6.34
Fibonacci 50% 5.86
Fibonacci 38.2% 5.37
Last Price 4.84
52-Week Low 3.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion